Acquired Inhibition of MicroRNA-124 Protects Against Spinal Cord Ischemia-reperfusion Injury Partially Through a Mitophagy-dependent Pathway
Overview
Affiliations
Objective: Mitophagy results in selective clearance of damaged mitochondria. We investigated whether mitophagy was involved in the neuroprotection by inhibiting microRNA (miRNA)-124 on ischemic spinal cords.
Methods: Inhibition of miRNA-124 was conducted by intrathecal injection of lentivirus vectors containing antagomiR-124. Spinal cord ischemia was induced in rats by crossclamping the descending aorta just distal to the left subclavian artery for 14 minutes. Hind-limb motor function was assessed with the motor deficit index (MDI). Lumbar spinal cords were harvested for ultrastructural, histologic examinations, and terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling staining. Mitophagy was evaluated by expressions of beclin-1 and LC3-II in mitochondria. Expressions of inhibitory member of the apoptosis-stimulating proteins of p53 family, p53, beclin-1, LC3-II, and miRNA-124 were measured by Western blot and quantitative real-time polymerase chain reaction. Mitophagy was inhibited by the antagonist of 3-methyladenine.
Results: Compared with control animals, antagomiR-124 significantly inhibited expressions of miRNA-124 (P < .01) and p53 (P < .05) and enhanced expressions of inhibitory member of the apoptosis-stimulating proteins of p53 family, becline-1 and LC3-II (P < .01, respectively) in spinal cords. MDI at 6, 12, 24, and 48 hours after reperfusion were markedly lower in antagomiR-124 group (P < .01, vs control group, respectively). More motor neurons and less apoptotic cells were detected in lumbar spinal cords of antagomiR-124 group (P < .01 vs control group). Administration of 3-methyladenine completely abolished enhancements of mitochondrial becline-1 and LC3-II by antagomiR-124 (P < .01 vs antagomiR-124 group) and partially inhibited effects of antagomiR-124 on MDI, number of motor neurons, and apoptotic cells (P < .01 or < .05 vs control group and antagomiR-124 group, respectively).
Conclusions: Inhibition of miRNA-124 exerts neuroprotection on spinal cords against ischemia-reperfusion injury, possibly by induction of mitophagy and antiapoptotic effects.
Xu S, Jia J, Mao R, Cao X, Xu Y Neural Regen Res. 2024; 20(9):2437-2453.
PMID: 39248161 PMC: 11801284. DOI: 10.4103/NRR.NRR-D-24-00432.
Macrophage polarization in spinal cord injury repair and the possible role of microRNAs: A review.
Wang J, Tian F, Cao L, Du R, Tong J, Ding X Heliyon. 2023; 9(12):e22914.
PMID: 38125535 PMC: 10731087. DOI: 10.1016/j.heliyon.2023.e22914.
He Z, Du J, Zhang Y, Xu Y, Huang Q, Zhou Q Theranostics. 2023; 13(2):849-866.
PMID: 36632224 PMC: 9830435. DOI: 10.7150/thno.74324.
Miao X, Lin J, Zheng X Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2022; 36(7):902-907.
PMID: 35848189 PMC: 9288914. DOI: 10.7507/1002-1892.202203081.
The roles of microRNAs in spinal cord ischemia-reperfusion injury.
Chen F, Tong X, Fang B, Wang D, Li X, Zhang Z Neural Regen Res. 2022; 17(12):2593-2599.
PMID: 35662187 PMC: 9165398. DOI: 10.4103/1673-5374.339471.